Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) Short Interest Update

Mydecine Innovations Group Inc. (OTCMKTS:MYCOF) was the recipient of a large growth in short interest in December. As of December 31st, there was short interest totalling 4,300 shares, a growth of 616.7% from the December 15th total of 600 shares. Based on an average daily volume of 1,496,000 shares, the days-to-cover ratio is currently 0.0 days.

Shares of OTCMKTS:MYCOF traded up $0.02 on Friday, hitting $0.18. 2,227,094 shares of the company’s stock were exchanged, compared to its average volume of 801,744. The firm’s 50-day moving average is $0.14 and its 200 day moving average is $0.26. Mydecine Innovations Group has a 1-year low of $0.01 and a 1-year high of $2.20.

Mydecine Innovations Group (OTCMKTS:MYCOF) last posted its earnings results on Tuesday, November 16th. The company reported ($0.02) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.01) by ($0.01).

Mydecine Innovations Group Company Profile

Mydecine Innovations Group, Inc operates as a life sciences company dedicated to the development and commercialization of adaptive pathway medicines, natural health products and digital health solutions. It encompasses three companies: Mindleap Health, Mydecine Health Sciences, and NeuroPharm Inc The Mindleap Health is an advanced digital health platform that helps people connect with mental health specialists who can empower them to thrive and develop habits for a healthy mind.

See Also: VIX – Volatility Index

Receive News & Ratings for Mydecine Innovations Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mydecine Innovations Group and related companies with MarketBeat.com's FREE daily email newsletter.